A detailed history of Essex Investment Management CO LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 82,668 shares of STIM stock, worth $64,481. This represents 0.03% of its overall portfolio holdings.

Number of Shares
82,668
Holding current value
$64,481
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.73 - $4.81 $143,015 - $397,633
82,668 New
82,668 $148,000
Q3 2021

Nov 09, 2021

SELL
$6.22 - $15.54 $1.18 Million - $2.96 Million
-190,163 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$10.15 - $17.25 $282,180 - $479,567
27,801 Added 17.12%
190,163 $3.05 Million
Q1 2021

May 12, 2021

BUY
$10.6 - $21.27 $297,489 - $596,942
28,065 Added 20.9%
162,362 $2.01 Million
Q4 2020

Feb 12, 2021

BUY
$4.95 - $11.45 $664,770 - $1.54 Million
134,297 New
134,297 $1.49 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $21.1M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.